Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Handong Global University Industry-Academic Cooperation Foundation has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 distinct examiners and 3 distinct art units, indicating separate examination paths.
DURYEE, ALEXANDER MARSH is associated with 1 pending matter. Counsel should use coordinated technical review for consistency, while tailoring each response to its assigned art unit and examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DURYEE, ALEXANDER MARSH | 1 | 33.3% | +41.7% |
| JACKSON III, WALTER | 1 | 50.0% | +0.0% |
| FAN, LYNN Y | 1 | 47.3% | +49.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18856355 | EXTRACELLULAR VESICLES ISOLATED FROM MESENCHYMAL STEM CELLS DERIVED FROM CHEMICALLY-INDUCED PLURIPOTENT STEM CELLS, AND USE THEREOF | JACKSON III, WALTER | — |
| 18886703 | COMPOSITION FOR PREVENTING AND IMPROVING GASTROINTESTINAL DISORDER CONTAINING LACTOBACILLUS PLANTARUM | FAN, LYNN Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19074320 | COMPOSITION FOR PREVENTION AND TREATMENT OF OBESITY OR INSULIN RESISTANCE SYNDROME COMPRISING LACTOBACILLUS PLANTARUM HAC03 AND RUTIN | DURYEE, ALEXANDER MARSH | — |
| 18886703 | COMPOSITION FOR PREVENTING AND IMPROVING GASTROINTESTINAL DISORDER CONTAINING LACTOBACILLUS PLANTARUM | FAN, LYNN Y | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| 1638 | 1 |
| 1759 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19074320 | COMPOSITION FOR PREVENTION AND TREATMENT OF OBESITY OR INSULIN RESISTANCE SYNDROME COMPRISING LACTOBACILLUS PLANTARUM HAC03 AND RUTIN | DURYEE, ALEXANDER MARSH | 1657 | §103 | Final Rejection | — | Pending | Mar 08, 2025 |
| 18856355 | EXTRACELLULAR VESICLES ISOLATED FROM MESENCHYMAL STEM CELLS DERIVED FROM CHEMICALLY-INDUCED PLURIPOTENT STEM CELLS, AND USE THEREOF | JACKSON III, WALTER | 1638 | §101§102§103§112 | Non-Final OA | — | Pending | Oct 11, 2024 |
| 18886703 | COMPOSITION FOR PREVENTING AND IMPROVING GASTROINTESTINAL DISORDER CONTAINING LACTOBACILLUS PLANTARUM | FAN, LYNN Y | 1759 | §103§112 | Non-Final OA | — | Pending | Sep 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHandong Global University Industry-Academic Cooperation Foundation has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Alexander Marsh Duryee has the most, with 1 of Handong Global University Industry-Academic Cooperation Foundation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
